Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Welby

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
Veterinary Immunology and Immunopathology|July 4, 2017
Field performance of six Mycobacterium avium subsp. paratuberculosis antigens in a 20h interferon gamma release assay in BelgiumKathy Dernivoix, Virginie Roupie, Sarah Welby, et al.
Preventive Veterinary Medicine|May 27, 2009
Identification of risk factors for the prevalence and persistence of Salmonella in Belgian broiler chicken flocksHarriet Namata, Sarah Welby, Marc Aerts, et al.
Vaccine|November 26, 2020
Hepatitis A antibody persistence 8 and 10 years after 1-dose and 2-dose vaccination in children from PanamaPatricia Juliao, Ivonne Abadia, Sarah Welby, et al.
Preventive Veterinary Medicine|January 7, 2016
Application of syndromic surveillance on routinely collected cattle reproduction and milk production data for the early detection of outbreaks of Bluetongue and Schmallenberg virusesAnouk Veldhuis, Henriëtte Brouwer-Middelesch, Alexis Marceau, et al.
Preventive Veterinary Medicine|March 12, 2018
Optimising cost-effectiveness of freedom from disease surveillance-Bluetongue Virus Serotype 8 as an exampleSimon R Rüegg, Sarah Welby, Hurria Yassin, et al.
Pharmacoepidemiology and Drug Safety|August 25, 2025
Real-World Use of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Axial Spondyloarthritis in the United States: Persistence, Variables Associated With Persistence, and Dosing VariationsMaureen Dubreuil, Jessica A Walsh, Atul Deodhar, et al.
Pharmacoepidemiology and Drug Safety|May 17, 2026
Transportability Analyses in Comparative Effectiveness Research: A Conceptual Framework and Methodological Principles Endorsed by the International Society for PharmacoepidemiologyBlythe Adamson, Wei Liu, Stephen Duffield, et al.
Human Vaccines & Immunotherapeutics|December 18, 2024
Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, ChinaJunting Yang, Sarah Welby, Zhike Liu, et al.
Human Vaccines & Immunotherapeutics|October 9, 2023
MOnitoring human papillomavirus Vaccine effect on Infection and cErvical diseases (MOVIE): Protocol for a cohort study using electronic health records from Yinzhou, ChinaSiwei Deng, Sarah Welby, Zhike Liu, et al.
RMD Open|January 4, 2023
Importance of quick attainment of minimal disease activity for a positive impact on lives of patients with psoriatic arthritisSelinde V J Snoeck Henkemans, Pascal H P de Jong, Jolanda J Luime, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Veterinary Immunology and Immunopathology|July 4, 2017
Field performance of six Mycobacterium avium subsp. paratuberculosis antigens in a 20h interferon gamma release assay in BelgiumKathy Dernivoix, Virginie Roupie, Sarah Welby, et al.
Preventive Veterinary Medicine|May 27, 2009
Identification of risk factors for the prevalence and persistence of Salmonella in Belgian broiler chicken flocksHarriet Namata, Sarah Welby, Marc Aerts, et al.
Vaccine|November 26, 2020
Hepatitis A antibody persistence 8 and 10 years after 1-dose and 2-dose vaccination in children from PanamaPatricia Juliao, Ivonne Abadia, Sarah Welby, et al.
Preventive Veterinary Medicine|January 7, 2016
Application of syndromic surveillance on routinely collected cattle reproduction and milk production data for the early detection of outbreaks of Bluetongue and Schmallenberg virusesAnouk Veldhuis, Henriëtte Brouwer-Middelesch, Alexis Marceau, et al.
Preventive Veterinary Medicine|March 12, 2018
Optimising cost-effectiveness of freedom from disease surveillance-Bluetongue Virus Serotype 8 as an exampleSimon R Rüegg, Sarah Welby, Hurria Yassin, et al.
Pharmacoepidemiology and Drug Safety|August 25, 2025
Real-World Use of Biologic and Targeted Synthetic Disease-Modifying Antirheumatic Drugs in Patients With Axial Spondyloarthritis in the United States: Persistence, Variables Associated With Persistence, and Dosing VariationsMaureen Dubreuil, Jessica A Walsh, Atul Deodhar, et al.
Pharmacoepidemiology and Drug Safety|May 17, 2026
Transportability Analyses in Comparative Effectiveness Research: A Conceptual Framework and Methodological Principles Endorsed by the International Society for PharmacoepidemiologyBlythe Adamson, Wei Liu, Stephen Duffield, et al.
Human Vaccines & Immunotherapeutics|December 18, 2024
Monitoring the safety of the adjuvanted human papillomavirus vaccine, HPV-16/18-AS04: Protocol for a cohort study using electronic health records in Yinzhou, ChinaJunting Yang, Sarah Welby, Zhike Liu, et al.
Human Vaccines & Immunotherapeutics|October 9, 2023
MOnitoring human papillomavirus Vaccine effect on Infection and cErvical diseases (MOVIE): Protocol for a cohort study using electronic health records from Yinzhou, ChinaSiwei Deng, Sarah Welby, Zhike Liu, et al.
RMD Open|January 4, 2023
Importance of quick attainment of minimal disease activity for a positive impact on lives of patients with psoriatic arthritisSelinde V J Snoeck Henkemans, Pascal H P de Jong, Jolanda J Luime, et al.
Pageof 4